{
    "2019-07-12": [
        [
            {
                "time": "2018-06-30",
                "original_text": "What Happened in the Stock Market Today",
                "features": {
                    "keywords": [
                        "Stock Market",
                        "Today"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Here's Why NeoGenomics Stock Rose 74% in the First Half of the Year",
                "features": {
                    "keywords": [
                        "NeoGenomics",
                        "Rose",
                        "74%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Aimmune Down on Negative ICER Review on Allergy Candidate",
                "features": {
                    "keywords": [
                        "Aimmune",
                        "Down",
                        "Negative",
                        "ICER",
                        "Review",
                        "Allergy"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Amgen & Novartis Alzheimer Studies End in Another Failure",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Novartis",
                        "Alzheimer",
                        "Studies",
                        "Failure"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Amgen",
                        "Scrap",
                        "Pivotal",
                        "Study",
                        "Alzheimer's",
                        "Prevention",
                        "Drug"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Futures",
                        "Illumina",
                        "Profitable",
                        "Marijuana",
                        "Stock",
                        "Tumble",
                        "Amgen",
                        "Novartis",
                        "Alzheimer's",
                        "Drug",
                        "Fails"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "Hookipa",
                        "Leaps",
                        "Illumina",
                        "Dims",
                        "Q2",
                        "Warning",
                        "Novartis",
                        "Amgen",
                        "Halt",
                        "Alzheimer's",
                        "Study"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}